Form 8-K · Current Report · Filed 2026-01-13
IDEXX Laboratories Announces CEO Transition with Michael Erickson Succeeding Jonathan Mazelsky
IDEXX Laboratories, Inc. announced on January 13, 2026, that Jonathan (Jay) Mazelsky will step down as President and Chief Executive Officer effective May 12, 2026, transitioning to the role of Executive Chair. Michael (Mike) Erickson, PhD, will succeed Mazelsky as President and CEO on the same date, bringing nearly two decades of leadership experience and significant healthcare technology and innovation expertise. Erickson entered into a letter agreement setting his base salary at $1,000,000 with a target bonus of 120% of base salary, and he is expected to receive a long-term incentive equity award with a target grant date value of not less than $7.8 million. Mazelsky will receive an annual base salary of $1,150,000 as Executive Chair and is expected to receive a grant of time-vesting restricted stock units with a target grant date value of not less than $8.275 million for the 2026 fiscal year.
- Filer
- Idexx Laboratories, Inc. IDXX · NASDAQ
- Filed
- Accession
- 0001104659-26-003103
- CIK
- 0000874716
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$724.76
Next session
-2.0%
Since filing
-22.9%
Latest close
$559.07
What happened, not what will happen — closing prices around the filing date.
About Idexx Laboratories, Inc.
Idexx Laboratories, Inc. is a prominent player in the health technology industry, specializing in veterinary diagnostics, software, and water microbiology testing. The company develops and markets products and services that enhance animal health and well-being, offering a wide range of diagnostic tests for companion animals, livestock, and poultry. It is notably recognized for providing innovative diagnostic services including in-house analyzers and rapid assays, which facilitate quick and accurate diagnostic results for veterinarians. Besides its veterinary focus, Idexx Laboratories also provides water testing solutions aimed at ensuring the safety and quality of water supplies by identifying microbial contaminants. The firm’s advanced diagnostic technologies significantly impact the animal health sector by delivering efficient, reliable diagnostics that enable proactive animal care. Idexx stands out as a key player in enhancing laboratory efficiency through its cloud-based practice management software, improving day-to-day operations for veterinary practices worldwide. Headquartered in Westbrook, Maine, Idexx Laboratories' mission and products underscore its vital role in advancing global animal health and environmental testing solutions, making it a significant entity in the health technology market.
Never miss another IDXX filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.